1.
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
by Mease, Philip J
The New England journal of medicine, October 2015, Vol.373(14), pp.1329-1339

2.
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
by Mcinnes, Iain B
Lancet (London, England), August 31, 2013, Vol.382(9894), pp.780-789
